Sign up
Pharma Capital

Diaceutics PLC makes strong start on London's AIM debut

Peter Keeling, chief executive of data analytics firm Diaceutics PLC (LON:DXRX), speaks to Proactive London's Andrew Scott as the firm began trading on London's AIM market.

The group collects laboratory, anonymised patient, and insurance claims data which it then provides to pharmaceutical companies to help them reach more patients who need to be on certain, specific drugs.

Diaceutics currently has data sets from over 2,500 labs including 3.5mln patient records.


View full DXRX profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.